Literature DB >> 6842195

Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.

J Sundquist, M L Forsling, J E Olsson, M Akerlund.   

Abstract

Arginine vasopressin (AVP) was determined in plasma and lumbar CSF from 46 patients with Parkinson's disease, dementia, cerebrovascular disease, multiple sclerosis and other, mostly peripheral neurological disorders. The mean plasma concentration of AVP was 1.62 microU/ml, the CSF concentration 1.14 microU/ml and the gradient CSF/plasma 0.72. There was a good correlation between the plasma and the CSF values in most patients. No sex difference could be found. A slight decrease of the CSF values could be found with increasing age. Significantly higher CSF-AVP values were found in patients with cerebrovascular disease, whereas lower CSF values were found in patients with dementia and Parkinson's disease. However there were decreased CSF/plasma gradients in patients with dementia and Parkinson's disease to about 0.30 compared to 0.98 in patients with peripheral neurological disorders. Patients with multiple sclerosis had an increased IgG index indicating an intrathecal IgG production but there was no obvious correlation between this and the AVP concentrations in plasma and CSF, nor with the total CSF protein content, nor with the albumin and IgG concentrations in plasma and CSF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842195      PMCID: PMC1027257          DOI: 10.1136/jnnp.46.1.14

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments.

Authors:  D de Wied
Journal:  Life Sci       Date:  1976-09-01       Impact factor: 5.037

Review 2.  Neurohypophyseal principles and memory processes.

Authors:  J M van Ree; B Bohus; D H Versteeg; D de Wied
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

3.  Primary dysmenorrhoea and vasopressin.

Authors:  M Akerlund; P Strömberg; M L Forsling
Journal:  Br J Obstet Gynaecol       Date:  1979-06

4.  Antidiuretic hormone in cerebrospinal fluid during endogenous and exogenous changes in its blood level.

Authors:  H Vorherr; M W Bradbury; M Hoghoughi; C R Kleeman
Journal:  Endocrinology       Date:  1968-08       Impact factor: 4.736

5.  Antidiuretic activity in the cerebrospinal fluid.

Authors:  H Heller; S H Hasan; A Q Saifi
Journal:  J Endocrinol       Date:  1968-06       Impact factor: 4.286

6.  Evidence for dopamine as an inhibitor of vasoprotein release in man.

Authors:  S L Lightman; M Forsling
Journal:  Clin Endocrinol (Oxf)       Date:  1980-01       Impact factor: 3.478

7.  Cerebrospinal fluid concentration of arginine vasopressin in children with bacterial meningitis.

Authors:  H Garcia; S L Kaplan; R D Feigin
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  A comparison between agar gel electrophoresis and CSF serum quotients of IgG and albumin in neurological disease.

Authors:  J E Olsson; B Pettersson
Journal:  Acta Neurol Scand       Date:  1976-04       Impact factor: 3.209

10.  Vasopressin in human cerebrospinal fluid.

Authors:  J S Jenkins; H M Mather; V Ang
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

View more
  4 in total

1.  Cerebrospinal fluid vasopressin in neurological and psychiatric disorders.

Authors:  P S Sørensen; A Gjerris; M Hammer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

2.  Oxytocin depolarizes fast-spiking hilar interneurons and induces GABA release onto mossy cells of the rat dentate gyrus.

Authors:  Scott W Harden; Charles J Frazier
Journal:  Hippocampus       Date:  2016-05-02       Impact factor: 3.899

Review 3.  Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Authors:  Félix J Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez
Journal:  Front Cell Neurosci       Date:  2014-11-11       Impact factor: 5.505

Review 4.  Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach.

Authors:  Karin D van Dijk; Charlotte E Teunissen; Benjamin Drukarch; Connie R Jimenez; Henk J Groenewegen; Henk W Berendse; Wilma D J van de Berg
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.